Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned

Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned

<i>Background</i>: The current treatment landscape of early stage lung cancer is rapidly evolving, particularly in <i>EGFR</i> mutant non-small cell lung cancer (NSCLC), where target therapy is moving to early stages. In the current review, we collected the available data exp...

Full description

Bibliographic Details
Main Authors: Lorenzo Belluomini, Silvia Teresa Riva, Michele Simbolo, Riccardo Nocini, Ilaria Trestini, Alice Avancini, Daniela Tregnago, Miriam Grazia Ferrara, Alberto Caldart, Alessandra Dodi, Anna Caliò, Emilio Bria, Aldo Scarpa, Michele Milella, Jessica Menis, Sara Pilotto
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cells
Subjects:
NSCLC
EGFR
early stage
early profiling
ADAURA
Online Access:https://www.mdpi.com/2073-4409/10/10/2685

Internet

https://www.mdpi.com/2073-4409/10/10/2685

Similar Items